forodesine hydrochloride (BCX-1777)

DRUG3 trials

Sponsors

BioCryst Pharmaceuticals

Conditions

B-cell Acute Lymphoblastic LeukemiaLeukemia, Lymphocytic, ChronicLeukemia, T-Cell

Phase 1

Forodesine Hydrochloride (BCX-1777) for B-Cell Acute Lymphoblastic Leukemia

CompletedNCT00289562

BioCryst PharmaceuticalsB-cell Acute Lymphoblastic Leukemia

Start: 2004-09-30End: 2007-12-31Target: 20Updated: 2012-01-20

Phase 2

Repeat-Dose of Forodesine Hydrochloride (BCX-1777) Infusion in Patients With Advanced T-Cell Leukemia

CompletedNCT00095381

BioCryst PharmaceuticalsLeukemia, T-Cell

Start: 2004-03-31End: 2007-12-31Target: 20Updated: 2012-01-19

Study of Forodesine Hydrochloride in Patients With Advanced, Fludarabine-refractory Chronic Lymphocytic Leukemia (CLL)

CompletedNCT00289549

BioCryst PharmaceuticalsLeukemia, Lymphocytic, Chronic

Start: 2005-06-30End: 2009-01-31Updated: 2012-02-08